Skip to main content

Blog

Recycled Rockets? Company Pioneers the First Reusable Rocket

If you’ve ever watched a rocket launch, you can imagine a familiar picture. The rocket moves slowly upward as it gives off a large gush of smoke. As the rocket speeds up and shoots through the atmosphere, flames trail behind it. Eventually, a part of the…

FDA Approves New Drug for Multiple Sclerosis

In Multiple Sclerosis, damage to the substance that coats neurons (myelin) causes impaired neural communication. Multiple sclerosis (MS) is a neurological disease that affects over 2 million people worldwide. In patients who suffer from MS, an abnormal…

How to be a Socially Conscious Scientist

by Katherine Wu My freshman year of college, I was given a choice: techie or fuzzy? And, before you ask, no, it wasn’t about creepy role-play. It was worse: my major. At Stanford, there were two kinds of people: those who studied the technical, hard…

Heart Disease Drug Faces Biggest Test Yet

Repatha’s clinical trial involved over 27,000 patients and cost over $1 billion. [‘The City’ from Herry Lawford] We just learned a lot more about a drug called Repatha, one of the newest weapons in the war against heart disease. …